Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamycin for Breast Cancer Prevention
NCT02642094Phase 2Terminated
- Start
- Jul 2016
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in breast cancer. Started Jul 2016; status: terminated.
02
Drugs
sirolimus
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02642094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02642094.